Trial Profile

A phase 1 open label, dose-escalation study to evaluate the safety, tolerability, and immunogenicity of a single booster dose of PIKA COVID-19 vaccine in healthy adults, who have completed a primary COVID-19 vaccine series

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 13 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 May 2024 According to a YS Biopharma media release, YS Biopharma company name changed to LakeShore Biopharma
14 Mar 2023 According to a YS Biopharma media release, the Yisheng Biopharma merged with Summit Healthcare Acquisition Corp and the combine company is named as YS Biopharma.
19 Nov 2022 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com